Results 271 to 280 of about 195,924 (307)

Neoadjuvant Therapy for Pancreatic Cancer

Journal of Gastrointestinal Surgery, 2008
Surgical resection is necessary but generally insufficient as curative treatment for pancreatic cancer. Traditionally, postoperative (adjuvant) therapies have been utilized in an attempt to improve outcome, yet these efforts have met with extremely limited success.
openaire   +2 more sources

NEOADJUVANT THERAPY OF ESOPHAGEAL CARCINOMA

Chest Surgery Clinics of North America, 1994
To quote Steiger, the "multimodality treatment of esophageal cancer brings creativity and imagination to a field of medicine plagued with failure." However, acceptance of neoadjuvant chemotherapy or chemoradiotherapy as routine must await the results of large phase III studies. Even with a positive response, many questions will remain.
openaire   +2 more sources

Neoadjuvant Therapy

The cancer journal from Scientific American, 2006
A A, Forastiere, S G, Urba, W, Liggett
openaire   +3 more sources

Neoadjuvant therapy for resectable melanoma

Clinical & Experimental Metastasis
The standard of care for patients with resectable stage III/IV melanoma classically included upfront resection with adjuvant therapy. However, in more recent years, the amount of systemic therapies available for neoadjuvant use for these patients has increased.
Cimarron E. Sharon, Giorgos C. Karakousis   +1 more
openaire   +2 more sources

[Resectable colorectal liver metastases: pro neoadjuvant therapy - contra neoadjuvant therapy].

Zeitschrift fur Gastroenterologie, 2011
Approximately one third of patients with colorectal cancer (CRC) present with metastases confined to the liver only. In 15 % of these patients the metastases are primarily resectable. After resection of colorectal liver metastases the 5-year survival rate is 25 - 40 %. The EORTC trial of Nordlinger et al.
D, Arnold, O, Stöltzing, S, Timm, A, Stein, M, Geissler, H, Lang   +5 more
openaire   +1 more source

Current and future cancer staging after neoadjuvant treatment for solid tumors

Ca-A Cancer Journal for Clinicians, 2021
James D Brierley Mb, Frcp, Daniel C Sullivan   +1 more
exaly  

NEOADJUVANT THERAPY

2012
Laurie Kirstein, Susan K. Boolbol, Mahmoud El-Tamer   +2 more
openaire   +2 more sources

Neoadjuvant Therapy With Bevacizumab

Journal of Clinical Oncology, 2006
Thomas, Gruenberger, Birgit, Gruenberger, Werner, Scheithauer   +2 more
openaire   +2 more sources

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

Ca-A Cancer Journal for Clinicians, 2022
William A Hal, X Allen Li, Christopher Schultz   +2 more
exaly  

Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer

Cancer Cell, 2022
Adele M. Nicolas, Markus Diefenhardt, Florian Buettner   +2 more
exaly